Lonza Expands Presence in China with GE Healthcare
Lonza has expanded its presence in China by signing a deal under which GE Healthcare will deliver a KUBio off-the-shelf biologics facility to Lonza in Guangzhou.
Biomanufacturing Bottlenecks
GEN's contributing editor K. John Morrow, Jr., PhD, recently spoke with several industry leaders to discuss the issue of bottlenecks in the biopharmaceutical industry and how they can be addressed as the industry evolves.
AGC Triples U.S. Biopharmaceutical Production Capacity
AGC plans to install an additional twelve 2,000L single-use animal-cell bioreactors at their Seattle AGC Biologics site, as well as establish a new contract development and manufacturing facility for microbial manufacturing.
Orchard Therapeutics to Build Out Gene Therapy Manufacturing Site in Fremont, CA
Orchard Therapeutics said it will build out a gene therapy manufacturing facility in Fremont, CA, that will employ 100 people and increase its manufacturing capabilities to support plans for an expanded pipeline.
The new facility,...
The Transparent CDMO: Maintaining Autonomy in Your Biomanufacturing Partnership
Sponsored Content Brought to you by
Collaboration with a contract development and manufacturing organization (CDMO) can make it possible to bring your drug to market — and to patients — faster, as additional resources allow...
Doubling Up Operations for Speed
Sponsored Content Brought to you by
In the business world, the mantra “fail fast” is often used to describe an approach where success can be achieved by knowing what to do and when to do...
Utilizing External Collaboration to Accelerate Vaccine Development
Sponsored Content Brought to you by
As the pharmaceutical industry continues to look for new and innovative ways to treat disease, some companies are putting more focus on how to prevent them. Vaccine development, while...
Customer Insights: Roivant Scales up Bioprocesses through a CDMO
Sponsored Content Brought to you by
Having been in the industry for more than 25 years, Patrick Guertin knows that cells can be temperamental and don’t like to be rushed, but in today’s biopharma industry speed to...
CDMO or No CDMO…That Is the Question
Sponsored Content Brought to you by
In the business world, the mantra “fail fast” is often used to describe an approach where success can be achieved by knowing what to do and when to do...
Single-Use Puzzles Come with Many Pieces
Before implementing single-use technology, biomanufacturers weigh many considerations: product volumes, processing modes (batch/continuous/hybrid), cleaning requirements, and much, much more.
